Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I Clinical research trials and Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I. Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.

Home > "P" Clinical Trials Conditions > Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I

Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I



Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I

For Condition: Attention Deficit Disorder with Hyperactivity
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this is study is to develop and implement a treatment that focuses on behaviors to reduce symptom severity and functional impairment in patients with Attention Deficit Hyperactivity Disorder, Predominantly Inattentive Type (ADHD-I). The long-term goal of this study is to apply the treatment to larger-scale trials to determine its effectiveness and generalizability.
Details: ADHD-I is a highly prevalent and serious childhood disorder that affects academic and social development. The symptoms of ADHD-I differ from those of the well-studied ADHD Combined Type. Unfortunately, studies of psychosocial interventions for ADHD-I are currently unavailable. Effective treatments for ADHD-I are still needed. Participants are randomly assigned to receive either a behavioral intervention or treatment as usual for 10 to 12 weeks. The behavioral intervention includes parent and child skill development groups, family meetings, and consultation with the child's teacher to address attention problems and areas of impairment at home and school. Parent and child interviews, teacher and child ratings, and psychoeducational testing are used to assess participants. Participants are assessed post-treatment and at a 2-month follow-up visit.
Eligibility:
Study Type:  Interventional, Treatment, Randomized, Active Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 7 Years/11 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - ADHD, Predominantly Inattentive Type - Public or private school attendance - English speaking
Total Enrollment: 60

Location and Contact Information:

HALP Clinic, Children's Center at Langley Porter, UCSF *Recruiting*
San Francisco,  California,  94143
United States
Recruiting Linda  Pfiffner 415-476-7418


Additional Information:
Study ID Numbers:  65927-01; 
Study Start Date: September 2002
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00071656

Other Attention Deficit Disorder With Hyperactivity Studies:
1. Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children

2. Brain Imaging in Children With AD/HD

3. Nutrient intake in children with attention deficit hyperactivity disorder

4. Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder

5. Genetic Aspects of Neurologic and Psychiatric Disorders

Related Studies:

Other Attention Deficit Disorder with Hyperactivity Clinical Trials
Other California Clinical Trials
Other San Francisco Clinical Trials

Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
Modify your Search

  Other Attention Deficit Disorder with Hyperactivity Clinical Trials
  Other California Clinical Trials
  Other San Francisco Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103